Insight

New study on overdiagnosis of prostate cancer in Europe – IARC

Photo taken from IARC/LinkedIn

Sep 10, 2024, 01:15

New study on overdiagnosis of prostate cancer in Europe – IARC

IARC – International Agency for Research on Cancer shared the following on LinkedIn:

“A paper on overdiagnosis of prostate cancer in Europe focuses on epidemiological characteristics of prostate cancer in Europe, and contrasts between heterogeneous incidence trends and more uniform decreases in mortality from prostate cancer.

Study published in The BMJ.”

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso

New study on overdiagnosis of prostate cancer in Europe - IARC

Read further.
Source: IARC – International Agency for Research on Cancer/LinkedIn

Anssi Auvinen cancer Diego Serraino epidemiology europe Freddie Bray IARC International Agency for Research on Cancer Luigino Dal Maso Mengmeng Li OncoDaily Oncology overdiagnosis prostate cancer Rune Kvale Salvatore Vaccarella The BMJ Valentina Lorenzoni

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action